We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
GSK’s scientific collaboration with Chinese biotech Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine is now being tested in human clinical trials.